Portal de Periódicos da CAPES

The Immunopathology of Gross Cystic Disease Fluid Proteins

1990; Wiley; Volume: 586; Issue: 1 Linguagem: Inglês

10.1111/j.1749-6632.1990.tb17806.x

1749-6632

Gwen Mazoujian, Darrow E. Haagensen,

Cystic Fibrosis Research Advances

Annals of the New York Academy of SciencesVolume 586, Issue 1 p. 188-197 The Immunopathology of Gross Cystic Disease Fluid Proteins GWEN MAZOUJIAN, GWEN MAZOUJIAN Department of Pathology Washington University School of Medicine 660 South Euclid Avenue St. Louis, Missouri 63110Search for more papers by this authorDARROW E. HAAGENSEN JR., DARROW E. HAAGENSEN JR. Department of Surgery The Jewish Hospital of St. Louis Washington University School of Medicine 216 South Kingshighway St. Louis, Missouri 63110 Department of Surgery, Washington University School of Medicine, Barnes Hospital Plaza, St. Louis, Missouri 63110.Search for more papers by this author GWEN MAZOUJIAN, GWEN MAZOUJIAN Department of Pathology Washington University School of Medicine 660 South Euclid Avenue St. Louis, Missouri 63110Search for more papers by this authorDARROW E. HAAGENSEN JR., DARROW E. HAAGENSEN JR. Department of Surgery The Jewish Hospital of St. Louis Washington University School of Medicine 216 South Kingshighway St. Louis, Missouri 63110 Department of Surgery, Washington University School of Medicine, Barnes Hospital Plaza, St. Louis, Missouri 63110.Search for more papers by this author First published: May 1990 https://doi.org/10.1111/j.1749-6632.1990.tb17806.xCitations: 24 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Benda, C. 1894. Das Verhaltnis der Michdruse zu den Geschwulsten. Dermatol. Z. 1: 94– 110. 2 Krompecher, E. 1916. Zur Histogenese und Morpholgie der Cystenmamma (maladie kystique reclus, cystadenoma Schimmelbuscin, mastitis chronica cystica Konig) des intrakanalikularen Kystadenomas und der Kystadenokarzinome der Brustdruse (Hidrokystoma, kystadenoma, Hidrokystadenocarzinoma mammae). Beitr. Pathol. Anat. 62: 403. 3 Wellings, S. R., H. M. Jensen & R. G. Marcum. 1975. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J. Nat. Cancer Inst. 55: 231– 243. 4 Wellings, S. R. & C. E. Alpers. 1987. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts. Hum. Pathol. 18: 381– 386. 5 Haagensen, D. E., Jr., G. Mazoujian, W. D. Holder, Jr., S. J. Kister & S. A. Wells, Jr. 1977. Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients. Ann. Surg. 185: 279– 285. 6 Haagensen, D. E., Jr., G. Mazoujian, W. G. Dilley, C. E. Pedersen, S. J. Kister & S. A. Wells, Jr. 1979. Breast gross cystic disease fluid analysis. I. Isolation and radioimmunoassay for a major component protein. J. Nat. Cancer Inst. 62: 239– 247. 7 Haagensen, D. E., Jr. & G. Mazoujian. 1986. Biochemistry and immunohistochemistry of gross cystic disease fluid proteins of the breast. In Diseases of the Breast. C. D. Haagensen, Ed. 3rd edit.: 474– 500. W. B. Saunders Co. Philadelphia , Pa . 8 Haagensen, C. D., C. Bodian & D. E. Haagensen, Jr. 1981. Breast Carcinoma Risk and Detection. W. B. Saunders Co. Philadelphia , Pa . 9 Mazoujian, G., G. S. Pinkus, S. Davis & D. E. Haagensen, Jr. 1983. Immunohistochemistry of a breast gross cystic disease fluid protein (GCDFP-15): a marker of apocrine epithelium and breast carcinomas with apocrine features. Am. J. Pathol. 110: 105– 111. 10 Mazoujian, G., T. H. Parish & D. E. Haagensen, Jr. 1988. Immunoperoxidase localization of GCDFP-15 with mouse monoclonal antibodies versus rabbit antiserum. J. Histochem. Cytochem. 36: 377– 382. 11 Charles, A. 1959. An electron microscopic study of the human axillary apocrine gland. J. Anat. 93: 226– 232. 12 Hibbs, R. G. 1962. Electron microscopy of human apocrine sweat glands. J. Invest. Dermatol. 38: 77– 84. 13 Biempica, L. & L. F. Montes. Secretory epithelium of the large axillary sweat glands: a cytochemical and electron microscopic study. Am. J. Anat. 117: 47– 72. 14 Murad, T. M. & E. vonHaam. 1968. The ultrastructure of fibrocystic disease of the breast. Cancer 22: 587– 600. 15 Pier, W. J., Jr., J. C. Garancis & J. F. Kulma. 1970. The ultrastructure of apocrine cells in intracystic papilloma and fibrocystic disease of the breast. Arch. Pathol. 89: 446– 452. 16 Ahmed, A. 1975. Apocrine metaplasia in cystic hyperplastic mastopathy. J. Pathol. 115: 211– 214. 17 Fisher, E. R. 1976. Ultrastructure of the human breast and its disorders. Am. J. Clin. Pathol. 60: 291– 375. 18 Hashimoto, K., B. G. Gross & W. F. Lever. 1966. Electron microscopic study of apocrine secretion. J. Invest. Dermatol. 46: 378– 390. 19 Mazoujian, G., M. J. Warhol & D. E. Haagensen, Jr. 1984. The ultrastructural localization of gross cystic disease fluid protein (GCDFP-15) in breast epithelium. Am. J. Pathol. 116: 305– 310. 20 Schaumberg-Lever, G. & W. F. Lever. 1975. Secretion from human apocrine glands: an electron microscopic study. J. Invest. Dermatol. 64: 38– 41. 21 Claus, R. & W. Alsing. 1976. Occurrence of 5 alpha-androst-16-en-3-one, a boar pheromone, in man and its relationship to testosterone. J. Endocrinol. 68: 483– 484. 22 Gower, D. B. 1972. 16-unsaturated C19 steroids. A review of their chemistry, biochemistry and possible physiologic role. J. Steroid. Biochem. 3: 45– 103. 23 Labows, J. N., G. Preti, E. Hoelzle, J. Leyden & A. Kilgman. 1979. Steroid analysis of human apocrine secretion. Steroids 34: 249– 258. 24 Brown-Grant, K. & W. Taylor. 1963. Response of the submandibular gland of the castrated mouse to local and systemic administration of steroids. J. Endocrinol. 26: 517– 523. 25 Wales, N. A. M. & F. J. Ebling. 1971. The control of the apocrine glands of the rabbit by steroid hormones. J. Endocrinol. 51: 763– 770. 26 Mazoujian, G. & R. Margolis. 1988. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Am. J. Dermatopathol. 10: 28– 35. 27 Mazoujian, G., G. S. Pinkus & D. E. Haagensen, Jr. 1984. Extramammary Paget's disease: evidence for an apocrine origin. Am. J. Surg. Pathol. 8: 43– 50. 28 Merot, Y., G. Mazoujian, G. Pinkus, T. K. Montaz & G. F. Murphy. 1985. Extramammary Paget's disease of the perianal and perineal regions: evidence of apocrine derivation. Arch. Dermatol. 121: 750– 752. 29 LeDoussal, V., P. F. Zangerle, J. Collette, et al. 1985. Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt. 15,000. Eur. J. Can Clin. Oncol. 21: 715– 725. 30 Eusebi, V., R. R. Millis, M. G. Cattani, G. Bussolati & J. G. Azzopardi. 1986. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study. Am. J. Pathol. 123: 532– 541. 31 Mazoujian, G., C. Bodian, D. E. Haagensen, Jr. & C. D. Haagensen. 1989. Expression of GCDFP-15 in breast carcinomas: Relationship to pathologic and clinical factors. Cancer 63: 2156– 2161. 32 Kelton, C. A. & J. E. Monahan. 1986. Androgen induction of CDP MRNA, a human breast tumor marker. ICSU Short Rep. 4: 300– 302. 33 Chalbos, A., D. Haagensen, T. Parish & H. Rochefort. 1987. Identification of two androgen regulated proteins released by T47D breast cancer cells. Cancer Res. 47: 2787– 2792. 34 Haagensen, D. E., Jr., J. S. Silva, G. S. Leight, W. G. Dilley & S. A. Wells, Jr. 1981. Fluoxymesterone stimulates plasma concentrations of gross cystic disease fluid protein in patients with metastatic breast carcinoma. Surg. Forum 32: 413– 414. 35 Dilley, W. G., G. S. Leight, Jr., J. S. Silva, S. Ammirata, D. E. Haagensen, Jr. & S. A. Wells, Jr. 1983. Androgen stimulation of gross cystic disease fluid protein and carcinoembryonic antigen in patients with metastatic breast carcinoma. J. Nat. Cancer Inst. 70: 69– 74. 36 Miller, W. R., A. A. Shivas, P. Franchimont & D. E. Haagensen, Jr. 1988. Breast gross cystic disease protein 15 in human breast cancer in culture. Eur. J. Cancer Clin. Oncol. 24: 223– 228. 37 Pearlman, W. H., J. D. Giueriguian & M. E. Sawyer. 1973. A specific progesterone-binding component of human breast cyst fluid. J. Biol. Chem. 248: 5736– 5741. 38 Pearlman, W. H., L. H. Peng, G. Mazoujian, D. E. Haagensen, Jr., S. A. Wells, Jr. & S. J. Kister. 1977. A specific progesterone-binding component of human breast cyst fluid. Its isolation and characterization. J. Endocrinol. 75: 19– 20. 39 Mazoujian, G. 1989. Immunohistochemistry of GCDFP-24 and zinc alpha2glycoprotein in benign sweat gland tumors. Lab. Invest. 60: 60A. 40 Poortmans, J. R. & K. Schmid. 1968. The level of zinc alpha2glycoprotein in normal human body fluids and kidney extract. J. Lab. Clin. Med. 71: 807– 811. 41 Bundred, N. J., W. R. Miller & R. A. Walker. 1987. An immunohistochemical study of the tissue distribution of breast cyst fluid protein, zinc alpha2glycoprotein. Histopathology 11: 603– 610. 42 Mazoujian, G. & D. E. Haagensen, Jr. 1989. Divergent expression of cystic disease fluid proteins and estrogen receptors in breast carcinomas. Lab. Invest. 60: 60A. Citing Literature Volume586, Issue1Biochemistry of Breast Cyst Fluid: Correlation with Breast Cancer RiskMay 1990Pages 188-197 ReferencesRelatedInformation